2019
DOI: 10.1038/s41419-019-1878-5
|View full text |Cite
|
Sign up to set email alerts
|

TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis

Abstract: Reactive oxygen species (ROS) regulate cell fate, although signaling molecules that regulate ROS hormesis remain unclear. Here we show that transmembrane 4 L six family member 5 (TM4SF5) in lung epithelial cells induced the alternatively spliced CD44v8-10 variant via an inverse ZEB2/epithelial splicing regulatory proteins (ESRPs) linkage. TM4SF5 formed complexes with the cystine/glutamate antiporter system via TM4SF5- and CD44v8-10-dependent CD98hc plasma-membrane enrichment. Dynamic TM4SF5 binding to CD98hc r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
7

Relationship

6
1

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 29 publications
(46 reference statements)
0
14
0
Order By: Relevance
“…TM4SF5 plays regulatory roles in the intracellular trafficking of other membrane proteins and receptors [ 32 ]; it binds to different membrane proteins and receptors, changing their intracellular locations between lysosomal and PMs, presumably leading to changes in signaling activity [ 20 , 22 ]. TM4SF5 binds to EGFR [ 30 ], integrin α5 [ 30 , 33 ], CD133 [ 34 ], CD151 [ 35 ], CD44 [ 36 ], CD98hc/SLC7A11 [ 37 ], SLC27A2/SLC27A5 [ 38 ], and mTOR [ 28 ]. Similarly, TM4SF5 may cause GLUT8 to be trafficked to the PM from lysosomes, where TM4SF5 and GLUT8 are localized separately presumably to transport extracellular fructose.…”
Section: Discussionmentioning
confidence: 99%
“…TM4SF5 plays regulatory roles in the intracellular trafficking of other membrane proteins and receptors [ 32 ]; it binds to different membrane proteins and receptors, changing their intracellular locations between lysosomal and PMs, presumably leading to changes in signaling activity [ 20 , 22 ]. TM4SF5 binds to EGFR [ 30 ], integrin α5 [ 30 , 33 ], CD133 [ 34 ], CD151 [ 35 ], CD44 [ 36 ], CD98hc/SLC7A11 [ 37 ], SLC27A2/SLC27A5 [ 38 ], and mTOR [ 28 ]. Similarly, TM4SF5 may cause GLUT8 to be trafficked to the PM from lysosomes, where TM4SF5 and GLUT8 are localized separately presumably to transport extracellular fructose.…”
Section: Discussionmentioning
confidence: 99%
“…At the T 5 ERMs for the TM4SF5-enriched microdomain, TM4SF5 can modulate localization, stability, expression, and signaling activity of its binding partners. One such complex forms with a cystine/glutamate antiporter, the xc À system consisting of CD98hc and xCT (SLC7A11), in response to reactive oxygen species (ROS)-generating stimuli for hormetic ROS modulation on lung epithelial cells (Kim et al, 2019). TM4SF5 also binds mTOR, SLC38A9 (an arginine transporter on lysosomal membranes), and L-arginine, playing roles in sensing physiological L-arginine in lysosomes for S6K1 activation and in pooling of cytosolic L-arginine during cell proliferation associated with HCC (Jung et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…PPARa signaling is upregulated in iWAT of cold-exposed mice (43). Furthermore, the PPARa agonist WY-14,643 has been shown to be effective in reducing WAT and BAT adiposity and suppressed inflammation in an HFD-induced mouse model (44). Since PPARa was investigated as a target for the activation of lipid catabolism to improve blood lipid profiles, TM4SF5 KO-induced PPARa signaling could be developed into a therapeutic target for clinical application.…”
Section: Discussionmentioning
confidence: 99%